Medication info
Olmesartan Medoxomil Plus Tablet 20/12.5 Milligrams

Olmesartan Medoxomil Plus Tablet 20/12.5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Round film-coated tablets with a light orange color
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201100981 · Approved 2011.02.25 · Insurance code 645404100

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
Before administering this drug, it is recommended that the dosage of olmesartan medoxomil or hydrochlorothiazide be adjusted separately. If blood pressure is not adequately controlled with either component alone, administer 1 tablet of this drug once daily, with or without food. Adjust the dose at intervals of 2~4 weeks, taking the patient's blood pressure response into consideration. A marked reduction in blood pressure may occur when olmesartan medoxomil is added or patients are switched to this drug (olmesartan medoxomil/hydrochlorothiazide) in patients taking high-dose hydrochlorothiazide monotherapy and in patients with volume depletion or hyponatremia. In such cases, reduce the hydrochlorothiazide dose to 12.5mg before adding olmesartan medoxomil. <Elderly patients> In elderly patients, start with the lowest dose and use caution when adjusting the dose, taking into consideration the patient's renal or cardiac function, comorbidities, and other concomitant medications. <Patients with renal failure> This drug (olmesartan medoxomil/hydrochlorothiazide) is generally administered to patients with mild to moderate renal failure (creatinine clearance>30mL/min). Do not administer this drug (olmesartan medoxomil/hydrochlorothiazide) to patients with more severe renal failure, as loop diuretics are preferable to thiazide diuretics in these patients. <Patients with hepatic failure> Use of this drug is not recommended in patients with hepatic failure because there is no experience with its use in these patients.
Child dose
Safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Used in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with Olmesartan Medoxomil or Hydrochlorothiazide. These medications help to effectively regulate blood pressure and prevent complications related to hypertension. It is primarily used as a combination therapy when patients have difficulty controlling blood pressure to improve their health condition.

How to take

Adult dose

Before administering this drug, it is recommended that the dosage of olmesartan medoxomil or hydrochlorothiazide be adjusted separately. If blood pressure is not adequately controlled with either component alone, administer 1 tablet of this drug once daily, with or without food. Adjust the dose at intervals of 2~4 weeks, taking the patient's blood pressure response into consideration. A marked reduction in blood pressure may occur when olmesartan medoxomil is added or patients are switched to this drug (olmesartan medoxomil/hydrochlorothiazide) in patients taking high-dose hydrochlorothiazide monotherapy and in patients with volume depletion or hyponatremia. In such cases, reduce the hydrochlorothiazide dose to 12.5mg before adding olmesartan medoxomil. <Elderly patients> In elderly patients, start with the lowest dose and use caution when adjusting the dose, taking into consideration the patient's renal or cardiac function, comorbidities, and other concomitant medications. <Patients with renal failure> This drug (olmesartan medoxomil/hydrochlorothiazide) is generally administered to patients with mild to moderate renal failure (creatinine clearance>30mL/min). Do not administer this drug (olmesartan medoxomil/hydrochlorothiazide) to patients with more severe renal failure, as loop diuretics are preferable to thiazide diuretics in these patients. <Patients with hepatic failure> Use of this drug is not recommended in patients with hepatic failure because there is no experience with its use in these patients.

Child dose

Safety and efficacy in pediatric patients have not been established.

Precautions

This drug may cause serious harm to the fetus and newborns if administered to pregnant women during the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This drug should not be used in patients with certain allergies, kidney or liver diseases, and certain genetic issues. Caution is required in patients with very low blood pressure or weak kidney function, liver disease, etc., and blood pressure and kidney function should be regularly monitored during use. Dizziness or symptoms of low blood pressure may occur while taking this drug, so caution is needed when driving or operating hazardous machinery. During treatment, electrolyte levels in the blood may change, requiring regular blood tests, especially monitoring potassium levels. This drug may interact with other medications, so consult a doctor or pharmacist if taking other medicines. Women who are breastfeeding are advised to either stop breastfeeding or discontinue the medication, as it may affect the baby. Safety in children has not been established, so use in pediatrics should be approached carefully. The elderly may have reduced kidney and liver function, so treatment should begin with the lowest dose and should be monitored carefully. In case of overdose, symptoms such as low blood pressure and electrolyte imbalance may occur, so seek appropriate medical attention immediately. Additionally, if any unusual skin changes or acute lung symptoms appear during treatment, discontinue use and consult a doctor.

Side effects

nausea, hyperuricemia, dizziness, upper respiratory tract infection, headache, urinary tract infection, chest pain, low back pain, peripheral edema, vertigo, abdominal pain, dyspepsia, gastritis, diarrhea, elevated AST, elevated GGT, elevated ALT, hyperlipidemia, elevated creatine phosphokinase, hyperglycemia, arthritis, arthralgia, myalgia, cough, rash, hematuria, facial edema, asthenia, angioedema, anaphylactic reaction, vomiting, rhabdomyolysis, acute renal failure, increased serum creatinine, hair loss, pruritus, urticaria, palpitations, hypercholesterolemia, hyperuricemia, headache, fatigue, drowsiness, emotional blunting, restlessness, interstitial pneumonia, pulmonary edema, acute respiratory distress syndrome, orthostatic hypotension, arrhythmia, transient blurred vision, jaundice, hepatitis, acute cholecystitis, necrotizing vasculitis, interstitial pneumonia, dyspnea, facial flushing, photosensitivity, anaphylaxis, increased BUN, increased creatinine, acute kidney injury, interstitial nephritis, renal impairment, malaise, nasal congestion, erectile dysfunction, exacerbation of systemic lupus erythematosus, parathyroid disorder, muscle cramps, sensory disturbances, weakness, Stevens-Johnson syndrome, erythema multiforme, exfoliative dermatitis, toxic epidermal necrolysis, chronic malabsorption, intestinal vascular edema, autoimmune hepatitis, increased blood pressure, epistaxis, asthma

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to prevent exposure to air or moisture, and it is best stored at room temperature between 1 to 25 degrees Celsius. Storing it this way will help maintain the drug's effectiveness.

Appearance and packaging

Appearance

Round film-coated tablets with a light orange color

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.